Monday, September 20, 2021

telegram SH
Whatsapp 9787748839374893773 1

images 23 1609798193847

HomeNewsGeneral NewsNigerian Doctor Wins “Brain Tumor Research” Award In U.S.

Nigerian Doctor Wins “Brain Tumor Research” Award In U.S.

Nigerian Doctor Wins “Brain Tumor Research” Award In U.S.

A US-based Nigerian Doctor, Dr Chibawanye Ene has won the 2019 Ronald L. Bittner Award on Brain Tumor Research.

A statement from the Clinical Department, Applied Radiation Oncology U.S., said Ene received the award at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting held from April 13 to April 17 in San Diego.

Ene who is from Akpugo in Nkanu West Local Government Area of Enugu State, won the award with his research work on ‘Anti-PD-L1 Immunotherapy Enhances Radiation-induced Abscopal Response in Glioblastoma’.

It was reported that Immunotherapy is a type of cancer treatment that helps immune system fight cancer.

The immune system, made up of white blood cells, organs and tissues of the lymph system, helps the body fight infections and other diseases.

The Clinical Department stated Immunotherapy is a type of biological therapy.

Also, Glioblastoma, known as glioblastoma multiforme (GBM), is the most aggressive cancer that begins within the brain. Initially, signs and symptoms of glioblastoma are non-specific.

They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke.

Immunotherapy for glioblastoma has been largely unsuccessful in part, because molecular heterogeneity drives selective elimination of only a subset of tumor cells.

According to the statement, it appears that therapeutic success in patients would require achieving an abscopal effect, where following focused radiation therapy, non-targeted tumor cells are attacked by the immune system.

The statement further revealed to Freshreporters News that it remains unclear how glioblastoma respond to focused radiation in terms of failure location and whether immunotherapy could amplify the immune response to tumor outside the radiation field.

The result of the study’s experiment show that radiation combined with anti PD L1 therapy induces an immunological response to unirradiated glioblastoma.

The researchers are currently optimizing other treatment combinations that could also be readily assessed in phase I human clinical trials.

(NAN)


SEE HOW TO MAKE MONEY ON THIS PLATFORM>>[http://bit.ly/2PvYHfC]

Donate to support Freshreporters=>https://freshreporters.com/support




DISCLAIMER
For publication of your news content, articles, videos or any other news worthy materials, please send a mail to thefreshrepo [email protected]

For Advert and other info, you can send a WhatsApp Message to +2347050565443


Join thousands of readers to receive daily Latest News:

telegram iconJoin our Telegram Group

facebook iconLike our Facebook Page

whatsapp iconJoin our WhatsApp Group

twitter iconFollow Us on Twitter

facebook iconJoin Our FACEBOOK GROUP

instagram iconFollow Us on Instagram

youtube iconSubscribe to our YouTube Channel


. .

7 COMMENTS

Most Viewed news